This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Societe Diagnostica-Stago, Diagnostica Stago. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011-2015
Title: Bibi Shah Soltan Mirshahi: Innovator in Fibrin Assay Methods
Introduction
Bibi Shah Soltan Mirshahi is a notable inventor based in Villejuif, France. She has made significant contributions to the field of medical diagnostics, particularly in the assay of soluble fibrin. With a total of 3 patents to her name, her work has the potential to enhance the accuracy of fibrin measurements in clinical settings.
Latest Patents
One of her latest patents is a method for in vitro assay of soluble fibrin by generating specific degradation products. This invention involves bringing a sample into the presence of a plasminogen activator with high specificity for soluble fibrin (PA-Fb sp). The soluble fibrin count in the sample is measured by assessing the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined prior to the introduction of PA-Fb sp.
Career Highlights
Throughout her career, Bibi has worked with prominent organizations such as Assistance Publique-Hôpitaux De Paris and Société Diagnostica-Stago. Her experience in these institutions has allowed her to refine her expertise in medical diagnostics and contribute to innovative solutions in the field.
Collaborations
Bibi has collaborated with various professionals, including her coworker Jeannette Soria, who has also played a role in advancing their shared goals in medical research.
Conclusion
Bibi Shah Soltan Mirshahi's contributions to the field of fibrin assay methods exemplify her dedication to innovation in medical diagnostics. Her patents and collaborations reflect her commitment to improving healthcare outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile